Ligand Pharmaceuticals | LGND - 应收帐款人



金融业
股票价格
USD
资产
USD 2.19B
现金及等价物
USD 1.01B
销售成本
USD 11.31M
流动资产
USD 1.46B
流动负债
USD 46.74M
债务
USD 451.98M
EBIT
USD 56.62M
EBITDA
USD -14.3M
员工
68
EPS每股收益
USD 2.37
股本和储备
USD 967.52M
销售毛利
USD 100.41M
债务利息支出
USD 1.79M
利息收入
USD 6.66M
贷款资金
USD 446.9M
市值
USD 5.11B
净收入
USD 48.51M
营业费用
USD 55.1M
营业利润
USD 56.62M
普通股股本
USD 19.66M
PE价格收益
84.31
税前利润
USD -24.26M
销售收入
USD 83.7M
销售和管理费用
USD 29.12M
股票
USD 10.26M
贸易债权人
USD 9.41M
应收帐款人
USD 54.8M


应收帐款人 更改 日
Agenus USD 22.34M 107K 2026-03
Amgen USD 10.23B 1.09B 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Baxter International USD 1.86B 158M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Enviri Corporation USD 341.34M 27.84M 2025-12
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 215.32M 36.77M 2026-06
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merck USD 12.21B 435M 2026-03
Pacira USD 132.42M 6.78M 2026-06
Pfizer USD 16.19B 19M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 54.18M 4.06M 2026-06